Some common biomarkers that can be considered for neuronal injury during COVID-19 and AD include p-tau, neurofilament light chain protein (NFL), and glial fibrillary acidic protein (GFAp) microvascular injury [107,108,109,110,111,112]. This evidence concerns the gene GFAP and Alzheimer disease.